NASDAQ: NRC - National Research Corporation

Yield per half year: -40.68%
Sector: Healthcare

Share chart National Research Corporation


About

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

More details
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Выручка 0.128
EBITDA 0.0481
Число акций ао 0.02467 млрд
P/E 52.88
P/S 13.39
P/BV 52.1
EV/EBITDA 36.02
Цена ао 31.06
ISIN US6373722023
Сайт https://www.nrchealth.com
Див.доход ао 2.04
Дивиденд ао 0.24
Change price per day: 0% (23.49)
Change price per week: +6.34% (22.09)
Change price per month: -7.12% (25.29)
Change price per 3 month: -31.64% (34.36)
Change price per half year: -40.68% (39.6)
Change price per year: -45.38% (43.01)
Change price per year to date: -40.62% (39.56)


All parameters ⇨

Underestimation

Title Value Grade
P/S 13.39 1
P/BV 52.1 1
P/E 52.88 5
EV/EBITDA 36.02 5
Total:

Efficiency

Title Value Grade
ROA, % 24.49 7
ROE, % 51.2 10
Total:

Dividends

Title Value Grade
Div yield, % 1.2002 2
DSI 0.86 9
Total:

Debt

Title Value Grade
Debt/EBITDA 0.8478 9
Total:

Growth impulse

Title Value Grade
Profit growth, % 5.14 1
Share price growth, % 0 0
Dividend growth, % 46.38 9
Total:

Dividends, % Dividends Result of period Buy before Register closing date Payment before
0.3% 0.12 IV кв. 2023 25.03.2024 27.03.2024 11.04.2024
0.29% 0.12 III кв. 2023 26.12.2023 28.12.2023 12.01.2024

Institutions Volume Share, %
Kayne Anderson Rudnick Investment Management LLC 2881464 12.08
Blackrock Inc. 1065585 4.47
Morgan Stanley 943710 3.96
Vanguard Group Inc 934644 3.92
Conestoga Capital Advisors, LLC 780806 3.27
Dimensional Fund Advisors LP 636402 2.67
QV Investors Inc. 395102 1.66
Renaissance Technologies, LLC 373584 1.57
Geode Capital Management, LLC 356305 1.49
State Street Corporation 342475 1.44



Head Job title Payment Year of birth
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (69 years)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (59 years)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (51 year)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (48 years)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (52 years)
Ms. Linda Stacy Secretary N/A

Address: United States, Lincoln. NE, 1245 Q Street - open in Google maps, open in Yandex maps
Website: https://www.nrchealth.com